Product Information
DEXTROAMP-AMPHET ER 25 MG CAP is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.5016 per EA under NDC 57664034088. Its NADAC has been published 285 times since Sep 9, 2020.
FDA first approved this application on May 17, 2019.
DEXTROAMP-AMPHET ER 25 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine SulfateStrength
6.25; 6.25; 6.25; 6.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
57664034088
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA211715FDA Approved
5/17/2019
On Market Since
3/5/2020
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has been published 285 times since Sep 9, 2020, and over the history we have for it it has declined 55.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5016 per EA |
|---|---|
| All-time high | $1.1343 (Sep 16, 2020) |
| All-time low | $0.4173 (May 22, 2024) |
| 52-week high | $0.5709 |
| 52-week low | $0.4896 |
| Median price | $0.6002 |
| Average price | $0.6190 |
| Largest weekly change | +30.3% (Dec 18, 2024) |
| Weeks tracked | 285 |
| Tracking since | Sep 9, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-12.1%
3Y
-11.0%
5Y
-26.3%
All
-55.8%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 25 MG CAP, manufactured by Sun Pharmaceutical Industries Inc., is $0.5016 per EA (NDC 57664034088), effective Feb 18, 2026.
How has the price of DEXTROAMP-AMPHET ER 25 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has declined 55.8%. It has been tracked across 285 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 25 MG CAP?
Since Sep 9, 2020, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has ranged from a low of $0.4173 (May 22, 2024) to a high of $1.1343 (Sep 16, 2020), with a median of $0.6002 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 25 MG CAP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 25 MG CAP, is $0.4952 per EA — about 1% below DEXTROAMP-AMPHET ER 25 MG CAP.
Who manufactures DEXTROAMP-AMPHET ER 25 MG CAP?
DEXTROAMP-AMPHET ER 25 MG CAP (NDC 57664034088) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.